We are live on ! Find out more
VMD icon

Viemed Healthcare

103 hedge funds and large institutions have $246M invested in Viemed Healthcare in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 26 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $102K | Put options by funds: $17K

100% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 16

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

17% more funds holding

Funds holding: 88103 (+15)

13% more capital invested

Capital invested by funds: $218M → $246M (+$28.9M)

4.92% more ownership

Funds ownership: 58.6%63.51% (+4.9%)

16% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 31

Holders
103
Holders Change
+15
Holders Change %
+17.05%
% of All Funds
1.62%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
32
Increased
26
Reduced
31
Closed
16
Calls
$102K
Puts
$17K
Net Calls
+$85K
Net Calls Change
-$185K
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
51
Claret Asset Management
Quebec, Canada
$369K +$383K +37,711 New
Osaic Holdings
52
Osaic Holdings
Arizona
$368K +$92.8K +9,140 +31%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$355K +$369K +36,289 New
OAM
54
Oppenheimer Asset Management
New York
$346K -$538 -53 -0.1%
HIS
55
Harvest Investment Services
Illinois
$337K +$350K +34,477 New
ACA
56
Anchor Capital Advisors
Massachusetts
$324K -$275K -27,127 -45%
National Bank of Canada
57
National Bank of Canada
Quebec, Canada
$295K +$190K +18,741 +161%
CCIA
58
Campbell & Co Investment Adviser
Maryland
$284K +$129K +12,692 +78%
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$262K -$1.88M -185,129 -87%
JP Morgan Chase
60
JP Morgan Chase
New York
$260K -$298K -29,371 -52%
UBS Group
61
UBS Group
Switzerland
$238K +$204K +20,063 +468%
BA
62
Bard Associates
Illinois
$234K -$691 -68 -0.3%
SIC
63
Salem Investment Counselors
North Carolina
$234K +$90.4K +8,900 +59%
OSAM
64
O'Shaughnessy Asset Management
Connecticut
$233K -$14.9K -1,468 -6%
SRCM
65
Sage Rock Capital Management
New York
$228K +$26.4K +2,600 +13%
William Blair & Company
66
William Blair & Company
Illinois
$225K
Bank of America
67
Bank of America
North Carolina
$200K -$436K -42,910 -68%
BA
68
BCM Advisors
Louisiana
$196K
Deutsche Bank
69
Deutsche Bank
Germany
$182K +$189K +18,588 New
MIM
70
MetLife Investment Management
New Jersey
$177K +$184K +18,101 New
Mirae Asset Global Investments
71
Mirae Asset Global Investments
South Korea
$170K +$176K +17,377 New
JF
72
Jump Financial
Illinois
$169K -$83.7K -8,242 -32%
AIG
73
American International Group
New York
$161K +$167K +16,432 New
Walleye Capital
74
Walleye Capital
New York
$159K +$165K +16,271 New
GC
75
Globeflex Capital
California
$149K -$18.5K -1,825 -11%

VMD Hedge Fund Activity: Q2 2023 in Review

103 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q2 2023, worth a combined $246M — up 13% from $218M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new VMD positions and 16 closed out — a net gain of 16 holders — while 26 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $11.1M.

  • 103 institutional investors held Viemed Healthcare (VMD) as of Q2 2023, up from 88 in Q1 2023.
  • Funds reported $246M of Viemed Healthcare stock for Q2 2023, up 13% quarter-over-quarter.
  • 32 funds opened new Viemed Healthcare positions in Q2 2023 and 16 closed out, a net change of +16 holders.
  • The largest Viemed Healthcare buyer in Q2 2023 was BlackRock, an estimated $14.5M added.
  • The largest Viemed Healthcare seller in Q2 2023 was Thrivent Financial for Lutherans, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2023.